Research projects conducted by the German Breast Group
The German Breast Group conducts research into breast cancer, developing and implementing its own study concepts.
With the help of additional scientific research projects, we strive to gain further insights into this disease.
Research News
-
26.02.2021 January 2021: Final results of the MALE study
We are delighted to inform you that final results of the first randomized phase II MALE trial have been published in JAMA Oncology.
-
04.02.2021 December 2020: Effect of germline BRCA1/2 mutations on haematological toxicities after neoadjuvant chemotherapy.
A retrospective analysis investigating the effect of germline BRCA1/2 mutations on severe haematological toxicities in TNBC patients treated with chemotherapy has been published in European Journal of Cancer.
-
11.12.2020 November 2020: Effect of neoadjuvant chemotherapy on immune system in patients with TNBC
A translational research project evaluating effect of chemotherapy on different immune subsets in TNBC patients from GeparNuevo trial was published in Journal for ImmunoTherapy of Cancer
-
09.12.2020 GBG Research at SABCS Virtual Meeting 2020
Data on GBG study PenelopeB and several collaborative projects will be presented at the SABCS Virtual Meeting 2020.
-
13.11.2020 October 2020: Results from GeparOLA study
We are delighted to inform you that results from GeparOLA trial have been published in Annals of Oncology.
Paper of the month
Every month, we present an interesting paper.
-
18.11.2022 Desiree: dose escalation of everolimus published
We are proud to inform you that our article A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE; GBG 86) is now available online.